Back

Fish oil supplementation, circulating omega-3 fatty acids, and incident aortic valve stenosis: a propensity score-weighted study in the UK Biobank

31 August 2026 (14:15 - 15:00)
Organised by: Logo
Congress Presentation Part of: Pathophysiology and pharmacotherapy in the development of aortic stenosis Aortic Valve Stenosis ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Mr Maxim Eduard Annink

Amsterdam University Medical Centre (AUMC), Amsterdam (Netherlands (The))

6 More presentations in this session

Presentation thumbnail
Convergent plasma and valve-tissue omics link vitamin B12 bioavailability to aortic stenosis
Doctor V. Myasoedova (Milan, IT)
Abstract
Presentation thumbnail
Long non-coding RNA MIAT and MEG3 are crucial regulators of inflammation and calcification in aortic valve stenosis
Ms A. Utami (Bonn, DE)
Abstract
Presentation thumbnail
Stability of the valve-to-annular ratio (anatomical reserve) as a biological constant in symptomatic severe aortic stenosis across clinical phenotypes
Doctor S. Ali (Birmingham, GB)
Abstract
Presentation thumbnail
Prognostic value of lipoprotein(a) level in calcific aortic valve stenosis: insight from a prospective Chinese cohort
Professor N. Wu (Beijing, CN)
Abstract
Presentation thumbnail
Pressure gradient deviation predicts outcomes in mixed aortic valve disease: a novel stratification framework
Doctor Y. Kim (Seoul, KR)
Abstract

Access the full session

Session thumbnail
Pathophysiology and pharmacotherapy in the development of aortic stenosis

The Event

Event poster

ESC Congress 2026

31 August 2026 14:15 CET
You may be interested in
thumbnail
Congress Presentation
Plasma lipids and risk of aortic valve stenosis: A Mendelian randomization study
28 August 2020
thumbnail
Congress Presentation
Omega 3 fatty acid supplementation improves physical performance: a systematic review and meta-analysis of RCTs.
26 August 2022
thumbnail
Congress Presentation
Fish oil supplements increase atrial fibrillation risk in healthy individuals: a population-based cohort study and mendelian randomization analysis
29 August 2022
thumbnail
Congress Presentation
Eicosapentaenoic acid therapy is associated with decreased coronary plaque instability assessed using optical frequency domain imaging
3 September 2019

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources